Andy Metcalfe is a Professor at Warwick Clinical Trials Unit and Consultant Orthopaedic Surgeon at the University Hospital of Coventry and Warwickshire (UHCW). His clinical practice is in knee surgery including patellofemoral problems, sports surgery, osteotomy and joint replacement.

Andy graduated from the University of Sheffield and undertook his basic and higher surgical training in Cardiff and the All-Wales rotation. He completed a PhD at Cardiff University at the Versus Arthritis Biomechanics and Bioengineering Research Centre. His fellowships were in Bristol with Mr Andrew Porteous and Mr Jonathan Eldridge and in Sydney with Dr David Wood, before starting in Coventry in 2015.

He leads the thriving Trauma and Orthopaedics team at Warwick CTU, which delivers high quality clinical and translational research that is designed to positively impact the lives of patients. He leads multiple high-impact clinical trials, including START:REACTS (published in The Lancet and AJSM) as well as currently running trials such as RACER-Knee, METEOR2 and REPPORT. He led the Surgery, Pain and Rehabilitation group at Warwick CTU from 2017-2025, with over 40 team members and grants of over £10M, with numerous major trials funded and and high impact publications acorss a range of subjects. He was Research Lead for the British Association for Surgery of the Knee 2019-2023, is Secretary of the British Patellofemoral Society, and has been involved in multiple NICE guidelines. He has also led a spin-out company from Warwick (called Veriq) who are focused on effecitve delivery of commerical Medtech trials.

Andy has also led the clinical academic training in T&O at Warwick and UHCW since 2015, a successful programme taking people through foundation training, academic clinical fellow posts and PhD fellowships through to Clinical Lecturer posts and CCT.